Resumes & CV records
Resumes
Saeed Chaudhry
Govt Degree Collag Jhelum
Work:
Govt Degree Collag Jhelum
Saeed A Chaudhry, Age 424220 National St APT 3R, Flushing, NY 11368
Saeed Chaudhry Phones & Addresses
4220 National St APT 3R, Corona, NY 11368 (718) 507-4143
Alexandria, VA
Jamaica, NY
North Plainfield, NJ
Mentions for Saeed A Chaudhry
Govt Degree Collag Jhelum
Publications & IP owners
Us Patents
Nasal Formulations For The Treatment Of Allergies
US Patent:
2004008, Apr 29, 2004
Filed:
Oct 21, 2003
Appl. No.:
10/690233
Inventors:
Stefan Sharpe - Jersey City NJ, US
Joel Sequeira - Edison NJ, US
Varda Sandweiss - Forest Hills NJ, US
Mark Giordano - Roseland NJ, US
Saeed Chaudhry - Clifton NJ, US
Joel Sequeira - Edison NJ, US
Varda Sandweiss - Forest Hills NJ, US
Mark Giordano - Roseland NJ, US
Saeed Chaudhry - Clifton NJ, US
Assignee:
SCHERING CORPORATION
International Classification:
A61L009/04
G01N021/00
G01N021/75
G01N021/00
G01N021/75
US Classification:
424/045000, 436/164000
Abstract:
Disclosed is a method of determining the formation of a secondary structure of a thixotropic formulation, said method comprising a) placing an amount of said thixotropic formulation on a transparent object; b) capturing an image of said thixotropic formulation by back-scattered light by using a particle vision and measurement probe; c) converting said image to a video image; d) analyzing said video image to determine the amount of time it takes for the formation of said secondary structure within said thixotropic formulation, and novel formulations concerning the same.
Pharmaceutical Compositions
US Patent:
2005013, Jun 23, 2005
Filed:
Oct 18, 2004
Appl. No.:
10/967719
Inventors:
Julianne Berry - Westfield NJ, US
Jill Sherwood - Edison NJ, US
Saeed Chaudhry - Clifton NJ, US
Joel Sequeira - Edison NJ, US
Jill Sherwood - Edison NJ, US
Saeed Chaudhry - Clifton NJ, US
Joel Sequeira - Edison NJ, US
International Classification:
A61L009/04
A61K009/14
A61M011/00
A61K009/14
A61M011/00
US Classification:
424046000, 128200230
Abstract:
Disclosed are metered dose inhalers having a metering valve to deliver a dose containing an aerosol suspension formulation, said aerosol suspension formulation comprising: an effective amount of Mometasone Furoate, Formoterol or a combination thereof; a suspension medium selected from the group consisting of 1,1,1,2,3,3,3,-heptafluoropropane, 1,1,1,2-tetrafluoroethane; and a solvent that is ethanol; wherein said formulation contains less than about 500 μg of non-volatile residue as measured by ultraviolet spectroscopy.
Pharmaceutical Formulations
US Patent:
2007020, Aug 30, 2007
Filed:
Feb 7, 2007
Appl. No.:
11/672413
Inventors:
Julianne Berry - Westfield NJ, US
Saeed Chaudhry - Clifton NJ, US
Joel Sequeira - Ocean NJ, US
Lukeysha Kline - Toms River NJ, US
Susan D'Souza - Scotch Plains NJ, US
Saeed Chaudhry - Clifton NJ, US
Joel Sequeira - Ocean NJ, US
Lukeysha Kline - Toms River NJ, US
Susan D'Souza - Scotch Plains NJ, US
International Classification:
A61K 9/12
A61K 31/4245
A61K 31/573
A61K 31/7034
A61K 31/65
A61K 31/4245
A61K 31/573
A61K 31/7034
A61K 31/65
US Classification:
424045000, 514364000, 514171000, 514401000, 514649000, 514569000, 514570000, 514420000, 514629000, 514290000, 514217050, 514035000, 514037000, 514192000, 514154000, 514200000, 424641000, 514557000, 424737000, 514458000, 514474000
Abstract:
An aspect of the present invention provides for a medicament including a solution containing pleconaril or a pharmaceutically acceptable salt thereof, wherein at least one solvent comprising said solution is a pleconaril-dissolving glyceride oil, and the solution is suitable for inhalation administration as an aerosol mist.
Pharmaceutical Formulations
US Patent:
2007020, Aug 30, 2007
Filed:
Feb 7, 2007
Appl. No.:
11/672408
Inventors:
Julianne Berry - Westfield NJ, US
Saeed Chaudhry - Clifton NJ, US
Joel Sequeira - Ocean NJ, US
Lukeysha Kline - Toms River NJ, US
Susan D'Souza - Scotch Plains NJ, US
Saeed Chaudhry - Clifton NJ, US
Joel Sequeira - Ocean NJ, US
Lukeysha Kline - Toms River NJ, US
Susan D'Souza - Scotch Plains NJ, US
International Classification:
A61K 9/14
A61K 31/7048
A61K 31/7034
A61K 31/573
A61K 31/616
A61K 31/192
A61K 31/19
A61K 31/7048
A61K 31/7034
A61K 31/573
A61K 31/616
A61K 31/192
A61K 31/19
US Classification:
424046000, 514364000, 514171000, 514291000, 514165000, 514570000, 514569000, 514420000, 514629000, 514304000, 514154000, 514035000, 514037000, 514192000, 514200000, 514557000, 514029000, 424737000, 424641000, 514474000, 514458000
Abstract:
An aspect of the present invention provides for a medicament suitable for administration as a nasal inhalant including an aqueous carrier and suspended therein particulate pleconaril, the aqueous carrier including a thixotropic composition including microcrystalline cellulose and a polymer selected from an alkali metal carboxyalkylcellulose, a polyvinylpyrrolidone polymer, and mixtures thereof.
Pharmaceutical Formulations
US Patent:
2007020, Aug 30, 2007
Filed:
Feb 7, 2007
Appl. No.:
11/672400
Inventors:
Saeed Chaudhry - Clifton NJ, US
Julianne Berry - Westfield NJ, US
Joel Sequeira - Ocean NJ, US
Julianne Berry - Westfield NJ, US
Joel Sequeira - Ocean NJ, US
International Classification:
A61K 31/573
A61K 31/4245
A61K 31/4164
A61K 31/137
A61K 31/4245
A61K 31/4164
A61K 31/137
US Classification:
514171000, 514364000, 514649000, 514401000
Abstract:
An aspect of the present invention provides for a medicament including a solution containing pleconaril or a pharmaceutically acceptable salt thereof, wherein at least one solvent including the solution is a pleconaril-dissolving hydrofluorocarbon.
Pharmaceutical Compositions
US Patent:
2008006, Mar 13, 2008
Filed:
Nov 14, 2007
Appl. No.:
11/940046
Inventors:
Julianne Berry - Westfield NJ, US
Jill Sherwood - Edison NJ, US
Saeed Chaudhry - Clifton NJ, US
Joel Sequeira - Ocean NJ, US
Jill Sherwood - Edison NJ, US
Saeed Chaudhry - Clifton NJ, US
Joel Sequeira - Ocean NJ, US
International Classification:
A61K 31/56
A61M 11/00
A61M 11/00
US Classification:
514171000, 128200230
Abstract:
Disclosed are metered dose inhalers having a metering valve to deliver a dose containing an aerosol suspension formulation, said aerosol suspension formulation comprising: an effective amount of Mometasone Furoate, Formoterol or a combination thereof; a suspension medium selected from the group consisting of 1,1,1,2,3,3,3,-heptafluoropropane, 1,1,1,2-tetrafluoroethane; and a solvent that is ethanol; wherein said formulation contains less than about 500 μg of non-volatile residue as measured by ultraviolet spectroscopy.
Process For Producing Metered Dose Inhaler Formulations
US Patent:
2008006, Mar 20, 2008
Filed:
Nov 30, 2007
Appl. No.:
11/948688
Inventors:
Saeed Chaudhry - Clifton NJ, US
Stefan Sharpe - Jersey City NJ, US
Julianne Berry - Westfield NJ, US
Joel Sequeira - Ocean NJ, US
Stefan Sharpe - Jersey City NJ, US
Julianne Berry - Westfield NJ, US
Joel Sequeira - Ocean NJ, US
International Classification:
A61M 11/04
A61K 9/14
A61K 9/14
US Classification:
128200230, 424045000, 424046000
Abstract:
Disclosed are methods of introducing a suspension or solution of a medicament, preferably mometasone furoate anhydrous, into a metered dose inhaler container, said container having a valve attached thereto, said method comprising the steps of introducing mometasone furoate anhydrous, a surfactant and a chlorofluorocarbon free propellant into a vessel that is held under pressure to form a suspension or solution, circulating said suspension or solution from the vessel through a line which includes a filling head, bringing said filling head into communication with said metered dose inhaler container through said valve of said metered dose inhaler container, introducing a quantity of such suspension or solution into the container from the filling head of the line through said valve of said metered dose inhaler container, withdrawing said filling head from said metered dose inhaler container, and sealing said metered dose inhaler container, as well as the products produced thereby having an improved particle size distribution of the active ingredients in metered dose inhalers.
Pharmaceutical Formulations
US Patent:
2009022, Sep 3, 2009
Filed:
May 14, 2009
Appl. No.:
12/465939
Inventors:
Julianne Berry - Westfield NJ, US
Saeed M. Chaudhry - Clifton NJ, US
Joel Sequeira - Venice FL, US
Lukeysha Charisse Kine - Toms River NJ, US
Susan S. D'Souza - Marlborough MA, US
Saeed M. Chaudhry - Clifton NJ, US
Joel Sequeira - Venice FL, US
Lukeysha Charisse Kine - Toms River NJ, US
Susan S. D'Souza - Marlborough MA, US
International Classification:
A61K 31/56
A61K 31/422
A61K 31/422
US Classification:
514171, 514364
Abstract:
An aspect of the present invention provides for a medicament suitable for administration as a nasal inhalant including an aqueous carrier and suspended therein particulate pleconaril, the aqueous carrier including a thixotropic composition including microcrystalline cellulose and a polymer selected from an alkali metal carboxyalkylcellulose, a polyvinylpyrrolidone polymer, and mixtures thereof.
Amazon
Der Kaschmirkonflikt: Seine Ursachen, Sein Wesen Sowie Rolle U. Bemuhungen D. Vereinten Nationen (Materialien Zu Entwicklung Und Politik) (German Edition)
Author:
Mohammed Saeed Chaudhry
Publisher:
Weltforum Verlag
Binding:
Hardcover
ISBN #:
3803901464
EAN Code:
9783803901460
NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.